Authors

Not A Laughing Matter: Emerging Nitrous Oxide Regulatory Oversight

Laughing gas misuse is surging as nitrous oxide drug abuse spreads online

Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market

Second-line and later treatment options for synovial sarcoma are limited. Afamitresgene autoleucel is the first FDA-approved T-cell receptor therapy, demonstrating long-lasting responses and tolerable adverse effects in pretreated patients.

From Quick Wins to Long-Term Infrastructure: A Pharmacist's Roadmap for Antithrombotic Stewardship

Darren Triller, PharmD, walks through the relative ease and impact of each of the 5 ADAPT priority areas, makes the case for dashboard-driven population health management.

A Student Pharmacist’s Guide to HIV Medications

Pharmacy students must have a comprehensive understanding of antiretrovirals to ensure efficiency and optimization of patients’ medical treatment.

From the Infusion Chair to the System Level: What Nearly Losing My Life Taught Me About Site-of-Care Decisions

The Role of the Pharmacist in the Management of Psychosis in Parkinson Disease

Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.

Addressing Burnout in Pharmacy Residency: A Comprehensive Approach to Enhancing Well-Being

Initiatives aim to reduce residents' high rates of depression and increase self-care skills.

Insights From HOPA 2025: Pharmacists Discuss CAR-T Safety at a Comprehensive Cancer Center

Amir Ali, PharmD, BCOP, and Allison Hsieh, PharmD share insights from their presentation about cytokine release syndrome, ICANS, and CAR T-cell therapy.

Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events

The FDA approved oral semaglutide to reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes (T2D).

Apixaban vs Rivaroxaban: A Clearer Choice for VTE?

Although evidence supports safety of apixaban and rivaroxaban relative to warfarin, researchers have not directly compared their bleeding risk until last year.

ADA 2026: The Diabetes Education Gap Clinicians Can't Afford to Ignore

Pharmacy Times speaks with Joyce Lee, PharmD, APh, FCCP, BCPS, BCACP, CDCES, to breakdown the diabetes education gap that clinicians can't afford to ignore.

Emerging Targeted Therapies in Breast Cancer: Expanding HER2-Low and TROP-2 Breakthroughs Require Pharmacist Knowledge and Vigilance

ADCs are reshaping metastatic breast cancer and pharmacists' roles in treatment management.

Opinion: The Pseudoscience of Personalized Compounding Prioritizes Convenience and Cost Over Science and Safety

Mass-produced compounded GLP-1 drugs bypass FDA safeguards, raising sterility, quality, and supply-chain risks—putting patients at risk despite ending shortages.

Final CLL14 Analysis Confirms Durable Benefit With Fixed-Duration Venetoclax-Obinutuzumab in Frontline CLL

Data presented at EHA 2026 continue to support venetoclax plus obinutuzumab as a first-line treatment for patients with chronic lymphocytic leukemia (CLL).

John Green: "Tuberculosis Anywhere Is a Threat to People Everywhere"

Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.

Supporting Access to Precision Medicine in Community Care Settings

Precision medicine transforms cancer care, enhancing patient outcomes through targeted therapies, yet faces challenges in community access and biomarker testing.

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.

An Overview of Vitamins and Supplements in Multiple Sclerosis

By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.

The Next Phase of Vertical Integration: Wholesalers Follow the PBM Playbook

Combating the Post-Pandemic Pharmacy Workforce Shortage

The pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.

Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals

Thor Halfdanarson, MD, outlines real-world challenges in radiopharmaceutical production and delivery and highlights key questions for upcoming trials, including alpha vs beta emitters and long-term toxicity.

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

Early Detection and Interconnected Risk: The Role of Albuminuria in Kidney and Cardiovascular Disease

Albuminuria (uACR) flags early vascular damage linking chronic kidney disease and cardiovascular risk.

A Novel Agent, Incretin Mimetics, and Potential Pharmacologicals for the Management of MASH

Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

The Role of Physical Activity in Breast Cancer Risk Reduction and Survival

Pharmacists can educate patients on nonpharmacologic strategies that help improve survival outcomes.

Apixaban vs Rivaroxaban: A Clearer Choice for VTE?

Although evidence supports safety of apixaban and rivaroxaban relative to warfarin, researchers have not directly compared their bleeding risk until last year.

APhA 2025: Nakia Eldridge, PharmD, MBA, Highlights Must-See Sessions

Nakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.

RSV Vaccination as a Public Health Priority: Protecting Communities Through Pharmacy Access